Scan to get started on Sahi
Built for active traders and investors
A new age Broking platform with in-house Sahi charts, real-time AI intelligence, and flat ₹10 per order brokerage.
4.5 ★ | 23K+ Ratings | IFTA Startup of the year 2025 | 7M+ downloads
Built for single-screen high performance acrossOptions Buying
Options Buying
Options Buying
Introducing the new & improved Sahi Scalper 2.0
Analyse & execute on a multi-chart layout. Watch the Index and Option Charts, Call & Put, Option Chain, simultaneously without moving an eye from your P&L.
Seamless Options Trading with Powerful Tools
Stay nimble and execute faster than ever before – no matter the screen size.
Trade from Charts, at Sahi Speed
Sahi’s powerful charts are built in-house & give you full control over your trades. Manage risk, optimize entries and exits, and never miss a movement – all without leaving your chart.
Real-Time market intelligence with Sahi AI
Tracks trends, identifies breakouts, highlights the hottest stocks
Analyse, Trade Option Strategies With Confidence
Create strategies that work for you. More control, better results.
Personalized Trading:
Tailor Your Space and Strategy
Personalize your homepage layout to match your trading style. Set up your workspace the way you want it, with just the tools you need.
High Performance Trading
at Incredible Value
Pay only ₹10 per executed order.
Stay ahead with Sahi Markets
Fresh stories from the Sahi newsroom, updated every few minutes.
BEML Discloses Q2 Stake Holding By Abakkus Flexi Cap Fund
Institutional holding disclosures highlight continued interest in BEML, with Abakkus Flexi Cap Fund holding a 1.08% stake in Q2 (as stated in the source alert; not independently verified). The state-owned engineering company is supported by significant order inflow momentum, including recent mega contracts in high-speed rail and sleeper trainsets.
Canara Bank Reports Q2 Standalone Net Profit of ₹5,170 Crore
Canara Bank delivered a strong operational performance in Q2, posting a standalone net profit of ₹5,170 crore against market consensus of ₹4,800 crore. Asset quality metrics strengthened as GNPA contracted 24 basis points QoQ to 1.33%, supported by a reduction in NPA provisions to ₹1,339 crore.
Sakar Healthcare Begins Commercial Oncology Supplies from EU GMP Site for Global Expansion
Sakar Healthcare is accelerating its international oncology strategy leveraging commercial production at its EU GMP-certified facility. Expanding global product registrations and CDMO partnerships reinforce the company's margin profile against domestic price controls.
